Causes of failure of eradication of Helicobacter pylori -: Antibiotic resistance is the major cause, and susceptibility testing may help

被引：33

作者：

Jenks, PJ ^{[1
]}

机构：

[1] Univ Nottingham Hosp, Inst Infect & Immun, Nottingham NG7 2UH, England

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2002年 / 325卷 / 7354期

基金：

英国惠康基金;

关键词：

D O I：

10.1136/bmj.325.7354.3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3 / 4

页数：2

共 12 条

[1] Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy -: A meta-analytical approach [J].

Dore, MP ;

Leandro, G ;

Realdi, G ;

Sepulveda, AR ;

Graham, DY .

DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (01) :68-76

[2]

Houben MHMG, 1999, ALIMENT PHARM THER, V13, P1047

[3]

HUANG JQ, 1999, GUT S1, V45, P140

[4] Implications of antibiotic resistance in the management of Helicobacter pylori infection:: Canadian Helicobacter Study Group [J].

Hunt, RH ;

SMaill, FM ;

Fallone, CA ;

Sherman, PM ;

van Zanten, SJV ;

Thomson, ABR .

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 14 (10) :862-868

[5] Recommendations for susceptibility tests on fastidious organisms and those requiring special handling [J].

King, A .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 :77-80

[6] A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy [J].

Lee, M ;

Kemp, JA ;

Canning, A ;

Egan, C ;

Tataronis, G ;

Farraye, FA .

ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (19) :2312-2316

[7]

Malfertheiner P, 2002, ALIMENT PHARM THER, V16, P167, DOI 10.1046/j.1365-2036.2002.01169.x

[8] Helicobacter pylori susceptibility testing by disc diffusion [J].

McNulty, C ;

Owen, R ;

Tompkins, D ;

Hawtin, P ;

McColl, K ;

Price, A ;

Smith, G ;

Teare, L .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (04) :601-609

[9]

National Committee for Clinical Laboratory Standards, 1999, M100S9 NCCLS

[10] Review article:: treatment of Helicobacter pylori infection and factors influencing eradication [J].

Qasim, A ;

O'Morain, CA .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 :24-30

← 1 2 →